|
US2612503A
(en)
|
1949-04-19 |
1952-09-30 |
Smith Kline French Lab |
Basic ether-substituted isoquinolines
|
|
US2538341A
(en)
|
1949-09-20 |
1951-01-16 |
Smith Kline French Lab |
Method for producing 1-hydroxyisoquinolines
|
|
US3404157A
(en)
|
1965-02-24 |
1968-10-01 |
American Cyanamid Co |
Substituted pyrroloindazole compounds
|
|
BE790679A
(fr)
|
1971-11-03 |
1973-04-27 |
Ici Ltd |
Derives de l'indole
|
|
US4198415A
(en)
|
1979-01-22 |
1980-04-15 |
Eli Lilly And Company |
Prolactin inhibiting octahydro pyrazolo[3,4-g]quinolines
|
|
US4647667A
(en)
|
1982-11-03 |
1987-03-03 |
Eli Lilly And Company |
Octa- and deca-hydroquinoline intermediates
|
|
US4778894A
(en)
|
1983-09-26 |
1988-10-18 |
Eli Lilly And Company |
6 oxo-decahydroquinolines
|
|
US5358949A
(en)
|
1986-03-05 |
1994-10-25 |
Otsuka Pharmaceutical Co., Ltd. |
Carbostyril derivatives and salts thereof and anti-arrhythmic agents containing the carbostyril derivatives
|
|
DK158590D0
(da)
|
1990-07-02 |
1990-07-02 |
Lundbeck & Co As H |
Indolderivater
|
|
US6201129B1
(en)
|
1995-02-01 |
2001-03-13 |
Univ. College Cardiff Consultants |
Tricyclic derivatives and their use as anti-cancer agents
|
|
US5639780A
(en)
|
1995-05-22 |
1997-06-17 |
Merck Frosst Canada, Inc. |
N-benzyl indol-3-yl butanoic acid derivatives as cyclooxygenase inhibitors
|
|
JP2000072751A
(ja)
|
1998-08-26 |
2000-03-07 |
Tanabe Seiyaku Co Ltd |
イソキノリノン誘導体
|
|
GB9827882D0
(en)
*
|
1998-12-17 |
1999-02-10 |
Smithkline Beecham Plc |
Novel compounds
|
|
JP2000281654A
(ja)
|
1999-03-26 |
2000-10-10 |
Tanabe Seiyaku Co Ltd |
イソキノリン誘導体
|
|
GB9913083D0
(en)
|
1999-06-04 |
1999-08-04 |
Novartis Ag |
Organic compounds
|
|
FR2802532A1
(fr)
|
1999-12-17 |
2001-06-22 |
Sanofi Synthelabo |
Derives de 2-phenyl-quinoleine, leur preparation et leur application en therapeutique
|
|
BR0016878A
(pt)
*
|
1999-12-29 |
2002-10-08 |
Wyeth Corp |
Inibidores tricìclicos de cinases protéicas
|
|
US6638929B2
(en)
*
|
1999-12-29 |
2003-10-28 |
Wyeth |
Tricyclic protein kinase inhibitors
|
|
CN1452619A
(zh)
|
2000-07-26 |
2003-10-29 |
史密斯克莱·比奇曼公司 |
具有抗细菌活性的氨基哌啶喹啉和它们的氮杂等排的类似物
|
|
IL154981A0
(en)
|
2000-10-10 |
2003-10-31 |
Smithkline Beecham Corp |
Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppay-y-binding agents
|
|
US6906192B2
(en)
|
2000-11-07 |
2005-06-14 |
Bristol Myers Squibb Company |
Processes for the preparation of acid derivatives useful as serine protease inhibitors
|
|
US20030212085A1
(en)
|
2001-04-17 |
2003-11-13 |
Mccall Robert B. |
Treatment of fibromyalgia and chronic fatigue syndrome
|
|
US20040176361A1
(en)
|
2001-05-23 |
2004-09-09 |
Masakazu Fujio |
Fused heterocyclic compound and medicinal use thereof
|
|
US6706423B2
(en)
|
2001-12-27 |
2004-03-16 |
Lightronik Technology Inc. |
Organic EL device
|
|
TW200400963A
(en)
|
2002-05-21 |
2004-01-16 |
Wyeth Corp |
R-enantiomers of pyranoindole derivatives and the use thereof for the treatment of hepatitis C virus infection or disease
|
|
US7223785B2
(en)
|
2003-01-22 |
2007-05-29 |
Boehringer Ingelheim International Gmbh |
Viral polymerase inhibitors
|
|
WO2004108120A1
(en)
|
2003-06-11 |
2004-12-16 |
Pfizer Products Inc. |
Use of growth hormone secretagogues for treatment of fibromyalgia
|
|
JP2006528661A
(ja)
|
2003-07-25 |
2006-12-21 |
ファイザー・インク |
アミノピラゾール化合物およびｃｈｋ１阻害剤としての使用
|
|
US7208601B2
(en)
|
2003-08-08 |
2007-04-24 |
Mjalli Adnan M M |
Aryl and heteroaryl compounds, compositions, and methods of use
|
|
US7723352B2
(en)
|
2003-09-23 |
2010-05-25 |
Merck Sharp & Dohme |
Isoquinolinone potassium channel inhibitors
|
|
EA200700243A1
(ru)
|
2004-07-14 |
2007-08-31 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
Способы лечения гепатита с
|
|
US20070203209A1
(en)
|
2005-08-18 |
2007-08-30 |
Wilmin Bartolini |
Useful indole compounds
|
|
US8097644B2
(en)
|
2006-03-28 |
2012-01-17 |
Allergan, Inc. |
Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist
|
|
AU2007234408B2
(en)
|
2006-04-04 |
2011-05-19 |
Fibrogen, Inc. |
Pyrrolo- and thiazolo-pyridine compounds as HIF modulators
|
|
JP5421767B2
(ja)
|
2006-04-10 |
2014-02-19 |
ウィスコンシン・アルムニ・リサーチ・ファウンデーション |
ヒト胚性幹細胞を使用して薬学的化合物および他の化学物質の毒性を評価するための試薬および方法
|
|
TW200813054A
(en)
|
2006-06-02 |
2008-03-16 |
Elan Pharm Inc |
Fused, tricyclic sulfonamide inhibitors of gamma secretase
|
|
WO2008019357A2
(en)
|
2006-08-07 |
2008-02-14 |
Ironwood Pharmaceuticals, Inc. |
Indole compounds
|
|
WO2008143633A2
(en)
|
2007-01-10 |
2008-11-27 |
University Of Florida |
Compounds and methods for treatment of alpha-1 antitrypsin deficiency
|
|
US20100016285A1
(en)
|
2007-01-24 |
2010-01-21 |
Mochida Pharmaceutical Co., Ltd. |
Heterocyclidene-n-(aryl) acetamide derivative
|
|
JP5107589B2
(ja)
|
2007-02-13 |
2012-12-26 |
旭化成株式会社 |
インドール誘導体
|
|
RU2337915C1
(ru)
|
2007-03-14 |
2008-11-10 |
Общество с ограниченной ответственностью "Инжиниринговая компания "ИНКОМП-НЕФТЬ" |
Комплексонат нитрилотри(метиленфосфонато)-2-фенил-3-этил-8-оксихинолин натриевая соль в качестве ингибитора солеотложений
|
|
GB0722055D0
(en)
|
2007-11-09 |
2007-12-19 |
Argenta Discovery Ltd |
Compounds
|
|
DE102008022521A1
(de)
|
2008-05-07 |
2009-11-12 |
Bayer Schering Pharma Aktiengesellschaft |
1,4-Diaryl-pyrimidopyridazin-2,5-dione und ihre Verwendung
|
|
RS54165B1
(sr)
|
2008-04-16 |
2015-12-31 |
Karo Bio Ab |
Novi ligandi za estrogenski receptor
|
|
WO2009158587A1
(en)
|
2008-06-26 |
2009-12-30 |
Inspire Pharmaceuticals, Inc. |
Method for treating pulmonary diseases using rho kinase inhibitor compounds
|
|
WO2011056222A1
(en)
|
2009-11-05 |
2011-05-12 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Methods of treating disorders associated with protein aggregation
|
|
WO2011110852A1
(en)
|
2010-03-10 |
2011-09-15 |
Astrazeneca Ab |
Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
|
|
CA3034600C
(en)
|
2010-05-07 |
2020-11-10 |
Genentech, Inc. |
Pyridone and aza-pyridone compounds and methods of use
|
|
RU2589831C2
(ru)
|
2010-08-04 |
2016-07-10 |
Грюненталь Гмбх |
ЛЕКАРСТВЕННАЯ ДОЗИРОВАННАЯ ФОРМА, КОТОРАЯ СОДЕРЖИТ 6'-ФТОР-(N-МЕТИЛ- ИЛИ N, N-ДИМЕТИЛ-)-4-ФЕНИЛ-4', 9'-ДИГИДРО-3'Н-СПИРО[ЦИКЛОГЕКСАН-1, 1'-ПИРАНО[3, 4, b]ИНДОЛ]-4-АМИН
|
|
CN103140758B
(zh)
|
2010-09-24 |
2015-03-11 |
基立福疗法公司 |
免疫层析装置、方法和试剂盒
|
|
JPWO2012063753A1
(ja)
|
2010-11-08 |
2014-05-12 |
日本電気株式会社 |
インドール系化合物、並びにこれを用いた光電変換用色素、半導体電極、光電変換素子および光電気化学電池
|
|
US9012773B2
(en)
|
2011-02-14 |
2015-04-21 |
Nec Corporation |
Thiazole-based compound and uses thereof
|
|
EP3628327A1
(en)
|
2011-06-24 |
2020-04-01 |
The Regents of the University of Colorado, A Body Corporate |
Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
|
|
CN103239451A
(zh)
|
2012-02-10 |
2013-08-14 |
上海医学生命科学研究中心有限公司 |
吡咯并喹啉醌在治疗和/或预防肝纤维化中的应用
|
|
US20140135359A1
(en)
|
2012-11-12 |
2014-05-15 |
Louis C. Martineau |
Methods of designing, preparing, and using novel protonophores
|
|
EP2991654B1
(en)
*
|
2013-04-30 |
2018-11-21 |
Merck Sharp & Dohme Corp. |
Novel compounds that are erk inhibitors
|
|
AP2016008970A0
(en)
|
2013-07-10 |
2016-01-31 |
Bayer Pharma AG |
Benzyl-1h-pyrazolo[3,4-b]pyridines and use thereof
|
|
US9572794B2
(en)
|
2014-08-06 |
2017-02-21 |
Vanderbilt University |
Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists
|
|
WO2016154051A1
(en)
|
2015-03-20 |
2016-09-29 |
University Of Florida Research Foundation, Inc. |
Combination therapy for treating infections diseases
|
|
CN105061316B
(zh)
*
|
2015-07-17 |
2017-12-22 |
苏州大学 |
稠环类化合物、制备方法和用途
|
|
WO2017035418A1
(en)
|
2015-08-26 |
2017-03-02 |
Achillion Pharmaceuticals, Inc. |
Disubstituted compounds for treatment of immune and inflammatory disorders
|
|
SG10202103844WA
(en)
|
2015-12-30 |
2021-06-29 |
Genentech Inc |
Use of tryptophan derivatives for protein formulations
|
|
CN109414596B
(zh)
|
2016-05-12 |
2023-09-29 |
密歇根大学董事会 |
Ash1l抑制剂和用其进行治疗的方法
|
|
HUE060119T2
(hu)
|
2016-05-31 |
2023-02-28 |
Spexis Ag |
Béta-hairpin peptidomimetikum elasztáz gátló hatással és annak aeroszolos adagolási formái
|
|
UA126675C2
(uk)
|
2017-01-23 |
2023-01-11 |
Дженентек, Інк. |
Хімічні сполуки як інгібітори активності інтерлейкіну-1
|
|
UY37581A
(es)
|
2017-02-02 |
2018-08-31 |
Gilead Sciences Inc |
Compuestos para el tratamiento de la infección por virus de la hepatitis b
|
|
CN111163774A
(zh)
|
2017-05-26 |
2020-05-15 |
罗格斯新泽西州立大学 |
细菌外排泵抑制剂
|
|
CN109111426B
(zh)
|
2017-06-23 |
2021-12-14 |
中国科学院上海药物研究所 |
一类稠合双环杂芳基或芳基化合物，及其用途
|
|
CN110546150B
(zh)
|
2017-10-19 |
2021-12-21 |
江苏豪森药业集团有限公司 |
含吡唑基的三并环类衍生物、其制备方法和应用
|
|
JP7212693B2
(ja)
|
2017-11-01 |
2023-01-25 |
ブリストル－マイヤーズ スクイブ カンパニー |
ファルネソイドｘ受容体モジュレーターとしての架橋二環化合物
|
|
CN107698505A
(zh)
|
2017-11-20 |
2018-02-16 |
孙婷婷 |
一种诺得司他的制备方法
|
|
CR20200263A
(es)
|
2017-12-13 |
2020-07-26 |
Lupin Ltd |
Componentes heterocíclicos bicíclicos sustituidos como inhibidores de prmt5
|
|
CN111971278B
(zh)
|
2018-01-31 |
2023-08-11 |
默克专利有限公司 |
用作irak抑制剂的喹啉化合物及其用途
|
|
CA3103920C
(en)
*
|
2018-06-22 |
2025-09-16 |
Ucl Business Ltd |
COMPOUNDS FOR TREATING DISEASES MEDIATED BY ALPHA-1 ANTITRYPSIN
|
|
TWI748194B
(zh)
|
2018-06-28 |
2021-12-01 |
德商菲尼克斯 Ｆｘｒ有限責任公司 |
含有雙環核心部分之新穎lxr調節劑
|
|
CA3108388A1
(en)
|
2018-08-07 |
2020-02-13 |
Merck Sharp & Dohme Corp. |
Prmt5 inhibitors
|
|
EP3620164A1
(en)
|
2018-09-05 |
2020-03-11 |
Genoscience Pharma SAS |
Substituted 2,4 diamino-quinoline as new medicament for fibrosis, autophagy and cathepsins b (ctsb), l (ctsl) and d (ctsd) related diseases
|
|
JOP20210060A1
(ar)
|
2018-10-05 |
2023-01-30 |
Vertex Pharma |
معدلات لمضاد تريبسين ألفا-1
|
|
CN110776459B
(zh)
|
2019-03-19 |
2023-01-24 |
江苏知原药业股份有限公司 |
7-羟基-2-喹诺酮-二硫代氨基甲酸酯类胆碱酯酶抑制剂
|
|
US11884672B2
(en)
|
2019-05-14 |
2024-01-30 |
Vertex Pharmaceuticals Incorporated |
Modulators of alpha-1 antitrypsin
|
|
TW202116303A
(zh)
|
2019-10-02 |
2021-05-01 |
美商維泰克斯製藥公司 |
α—１抗胰蛋白酶缺乏症之治療方法
|
|
KR20220133227A
(ko)
|
2020-01-30 |
2022-10-04 |
버텍스 파마슈티칼스 인코포레이티드 |
알파-1 항트립신 결핍증의 치료 방법
|
|
CA3177531A1
(en)
|
2020-04-03 |
2021-10-07 |
Vertex Pharmaceuticals Incorporated |
Indole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd)
|
|
CN115697969B
(zh)
|
2020-04-03 |
2026-08-11 |
弗特克斯药品有限公司 |
α-1抗胰蛋白酶调节剂
|
|
AU2021247282A1
(en)
|
2020-04-03 |
2022-10-27 |
Vertex Pharmaceuticals Incorporated |
Modulators of alpha-1 antitrypsin
|
|
JP7732999B2
(ja)
|
2020-04-03 |
2025-09-02 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
アルファ１－アンチトリプシンのモジュレーター
|
|
AU2021247285A1
(en)
|
2020-04-03 |
2022-10-27 |
Vertex Pharmaceuticals Incorporated |
Modulators of alpha-1 antitrypsin
|
|
WO2021203007A1
(en)
|
2020-04-03 |
2021-10-07 |
Vertex Pharmaceuticals Incorporated |
Substituted 5-hydroxyindole compounds as modulators of alpha-1 antitrypsin
|
|
EP4188931A2
(en)
|
2020-07-27 |
2023-06-07 |
Vertex Pharmaceuticals Incorporated |
Processes for preparing modulators of alpha-1 antitrypsin
|
|
WO2022104353A1
(en)
|
2020-11-12 |
2022-05-19 |
Vertex Pharmaceuticals Incorporated |
Methods of monitoring alpha-1 antitrypsin (aat) deficiency by measuring polymerised aat
|
|
US20240002386A1
(en)
|
2020-11-17 |
2024-01-04 |
Vertex Pharmaceuticals Incorporated |
Solid forms of 4-(5-(4-fluorophenyl)-6-(tetrahydro-2h-pyran-4-yl)-1,5-dihydropyrrolo[2,3-f]indazol-7-yl)benzoic acid
|
|
TW202421121A
(zh)
|
2022-09-09 |
2024-06-01 |
美商維泰克斯製藥公司 |
α-１抗胰蛋白酶之調節劑
|